Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 243

Similar articles for PubMed (Select 10235429)

1.

Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.

Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J.

Thromb Haemost. 1999 Apr;81(4):506-10.

PMID:
10235429
2.

Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.

Ziakas PD, Poulou LS, Pavlou M, Zintzaras E.

Eur J Obstet Gynecol Reprod Biol. 2015 Jun 16;191:106-111. doi: 10.1016/j.ejogrb.2015.06.005. [Epub ahead of print] Review.

PMID:
26115054
3.

Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.

Wahba MA, Ismail MA, Saad AA, Habashy DM, Hafeez ZM, Boshnak NH.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):309-15. doi: 10.1097/MBC.0000000000000242.

PMID:
25565385
4.

Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population.

Adler G, Agnieszka G, Valjevac A, Czerska E, Kiseljakovic E, Salkic NN.

Ann Hum Biol. 2014 Oct 30:1-5. [Epub ahead of print]

PMID:
25357225
5.

Study of associated genetic variants in Indian subjects reveals the basis of ethnicity related differences in susceptibility to venous thromboembolism.

Kumari B, Srivastava S, Chatterjee T, Vardhan R, Tyagi T, Gupta N, Sahu A, Chandra K, Ashraf MZ.

Thrombosis. 2014;2014:182762. doi: 10.1155/2014/182762. Epub 2014 Sep 30.

6.

Is there a significant lower genetic susceptibility to venous thrombosis in the Basques?

Bauduer F.

Blood Coagul Fibrinolysis. 2014 Sep;25(6):645-7. doi: 10.1097/MBC.0000000000000101. No abstract available.

PMID:
25083731
7.

A deep vein thrombosis caused by 20209C>T mutation in homozygosis of the prothrombin gene in a Caucasian patient.

Alvarez SI, Ollero EB, Llinares Sanjuan FM, Martínez FL, Calvo Martín MT.

Biochem Med (Zagreb). 2014 Feb 15;24(1):159-66. doi: 10.11613/BM.2014.018. eCollection 2014.

8.

Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.

Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT.

Gene. 2014 Feb 15;536(1):171-6. doi: 10.1016/j.gene.2013.11.019. Epub 2013 Dec 12.

PMID:
24334115
9.

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.

Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S.

Eur J Epidemiol. 2013 Aug;28(8):621-47. doi: 10.1007/s10654-013-9825-8. Epub 2013 Jul 31.

10.

Prevalence of variants that confer risk for venous thromboembolism in an elderly population of northeastern Brazil.

Ferreira-Fernandes H, Costa PN, Fernandes HF, Araújo-Neto AP, Motta FJ, Canalle R, Yoshioka FK, Guerreiro JF, Burbano RR, Rey JA, Pinto GR.

Genet Mol Res. 2013 Mar 11;12(3):3698-707. doi: 10.4238/2013.Mach.11.5.

11.

Prothrombotic polymorphisms in patients with Raynaud's phenomenon and migraine.

Takáts AT, Shemirani AH, Zsóri KS, András C, Csiki Z.

Acta Physiol Hung. 2012 Dec;99(4):430-5. doi: 10.1556/APhysiol.99.2012.4.7.

PMID:
23238545
12.

Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries.

Adler G, Clark JS, Loniewska B, Czerska E, Salkic NN, Ciechanowicz A.

Bosn J Basic Med Sci. 2012 May;12(2):82-7.

13.

Polymorphism G-308A in the promoter of the tumor necrosis factor-α gene and its association with the risk of venous thromboembolism.

Horakova K, Chylkova A, Kolorz M, Bartosova L, Pechacek V, Starostka D, Wroblova K.

Blood Coagul Fibrinolysis. 2012 Jun;23(4):316-9. doi: 10.1097/MBC.0b013e3283527506.

PMID:
22473048
14.

Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.

Maharshak N, Halfon P, Deutsch V, Peretz H, Berliner S, Fishman S, Zelber-Sagi S, Rozovski U, Leshno M, Oren R.

World J Gastroenterol. 2011 Dec 7;17(45):5007-13. doi: 10.3748/wjg.v17.i45.5007.

15.

Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.

Pandey SK, Meena A, Kishor K, Mishra RM, Pandey S, Saxena R.

Clin Appl Thromb Hemost. 2012 Jun;18(3):320-3. doi: 10.1177/1076029611425830. Epub 2011 Nov 14.

PMID:
22084413
16.

Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.

Torun YA, Patiroglu T, Ozdemir MA, Ozkul Y, Ekici A, Karakukcu M.

Clin Appl Thromb Hemost. 2012 Mar-Apr;18(2):218-21. doi: 10.1177/1076029611412366. Epub 2011 Aug 25.

PMID:
21873357
17.

Vascular behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor V, and prothrombin.

Dagan E, Baruch Y, Fiorilli M, Rozenbaum M, Rosner I, Gershoni-Baruch R.

Genet Test Mol Biomarkers. 2012 Jan;16(1):30-5. doi: 10.1089/gtmb.2011.0096. Epub 2011 Aug 23.

PMID:
21861708
18.

PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease.

Atzeni F, Boiardi L, Nicoli D, Farnetti E, Casali B, Sarzi-Puttini P, Pipitone N, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, Salvarani C.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S38-43. Epub 2011 Sep 27.

PMID:
21813062
19.

Genetic polymorphisms and cerebrovascular disease in children with sickle cell anemia from Rio de Janeiro, Brazil.

Filho IL, Leite AC, Moura PG, Ribeiro GS, Cavalcante AC, Azevedo FC, Andrada-Serpa MJ.

Arq Neuropsiquiatr. 2011 Jun;69(3):431-5.

20.

Protease activated receptor 1 gene -506 I / D polymorphism in cancer patients with and without venous thrombosis.

Karabıyık A, Eroğlu A, Akar N.

Eur J Haematol. 2011 Jun;86(6):546-7. doi: 10.1111/j.1600-0609.2011.01600.x. Epub 2011 Apr 7. No abstract available.

PMID:
21375587
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk